# Zhengye Biotechnology Holding Limited (ZYBT)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ZYBT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 80.05M | ¥ -71.29M | ¥ 39.08M | ¥ 75.08M | ¥ 249.85M |
| 2024 | N/A | N/A | N/A | ¥ 86.43M | ¥ 283.96M |
| 2023 | N/A | N/A | N/A | ¥ 89.85M | ¥ 272.85M |
| 2022 | N/A | N/A | N/A | ¥ 64.88M | ¥ 296.50M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.30 |
| Liabilities / Eq | 0.52 |
| Current Ratio | 1.14 |

## Other views

- [Metrics](https://sponda.capital/en/ZYBT.md)
- [Charts](https://sponda.capital/en/ZYBT/charts.md)
- [Compare](https://sponda.capital/en/ZYBT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.